Global Whole Genome and Exome Sequencing Market was valued at USD 1.91 Billion in 2023 and is expected to reach USD 4.01 Billion by 2029 with a CAGR of 13.32% during the forecast period. The Whole Genome and Exome Sequencing Market is characterized by intense competition among leading players. Major companies driving innovation include: Agilent Technologies, Inc. Thermo Fisher Scientific, Inc. Bio-Rad Laboratories, Inc. Eurofins Scientific SE F. Hoffmann-La Roche Ltd Illumina, Inc. Laboratory Corporation of America Holdings Novogene Corporation Pacific Biosciences of California, Inc.